| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Friday’s Close |
|---|---|---|---|---|---|
| NVS | Novartis AG | $85.13 | $197.65B | N/A |
Anheuser-Busch InBev SA/NV (BUD) Q4 2019 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2020/02/27/anheuser-busch-inbev-sanv-bud-q4-2019-earnings-cal.aspx?source=iedfolrf0000001
Feb 27, 2020 - BUD earnings call for the period ending December 30, 2019.
0
Anheuser-Busch InBev SA/NV (BUD) CEO Carlos Brito on Q4 2019 Results - Earnings Call Transcript
https://seekingalpha.com/article/4327866-anheuser-busch-inbev-sa-nv-bud-ceo-carlos-brito-on-q4-2019-results-earnings-call-transcript?source=feed_sector_transcripts
Feb 27, 2020 - Anheuser-Busch InBev SA/NV (NYSE:BUD) Q4 2019 Earnings Conference Call February 27, 2020 9:00 AM ET Company Participants Carlos Brito - Chief Executive Officer Felipe Dutra - Chief Financial & Sol
0
Anheuser-Busch InBev SA/NV 2019 Q4 - Results - Earnings Call Presentation
https://seekingalpha.com/article/4327676-anheuser-busch-inbev-sa-nv-2019-q4-results-earnings-call-presentation?source=feed_all_articles
Feb 27, 2020 - The following slide deck was published by Anheuser-Busch InBev SA/NV in conjunction with their 2019 Q4 earnings call.
0
Bayer (BAYRY) Q4 Earnings Beat Estimates, Sales Rise Y/Y
http://www.zacks.com/stock/news/786768/bayer-bayry-q4-earnings-beat-estimates-sales-rise-y-y?cid=CS-ZC-FT-analyst_blog|earnings_article-786768
Feb 27, 2020 - Bayer (BAYRY) beats earnings estimates in the fourth quarter of 2019.
0
ASM International NV 2019 Q4 - Results - Earnings Call Presentation
https://seekingalpha.com/article/4327364-asm-international-nv-2019-q4-results-earnings-call-presentation?source=feed_all_articles
Feb 26, 2020 - The following slide deck was published by ASM International NV in conjunction with their 2019 Q4 earnings call.
0
U.S. and EU Regulators Reviewing Novartis' Leukemia Drug for Expanded Approval in Multiple Sclerosis
https://www.fool.com/investing/2020/02/24/us-and-eu-regulators-reviewing-novartis-leukemia-d.aspx?source=iedfolrf0000001
Feb 24, 2020 - A pair of phase 3 trials offer strong evidence that ofatumumab is more effective than Sanofi's Aubagio.
0
Sapiens International Corporation NV (SPNS) Q4 2019 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2020/02/24/sapiens-international-corporation-nv-spns-q4-2019.aspx?source=iedfolrf0000001
Feb 24, 2020 - SPNS earnings call for the period ending December 31, 2019.
0
Galapagos NV (GLPG) Q4 2019 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2020/02/21/galapagos-nv-glpg-q4-2019-earnings-call-transcript.aspx?source=iedfolrf0000001
Feb 21, 2020 - GLPG earnings call for the period ending December 31, 2019.
0
Galapagos NV (GLPG) CEO Onno van de Stolpe on Q4 2019 Results - Earnings Call Transcript
https://seekingalpha.com/article/4326242-galapagos-nv-glpg-ceo-onno-van-de-stolpe-on-q4-2019-results-earnings-call-transcript?source=feed_sector_healthcare
Feb 21, 2020 - Galapagos NV (NASDAQ:GLPG) Q4 2019 Earnings Conference Call February 21, 2020 08:00 AM ET Company Participants Elizabeth Goodwin - Vice President, Investor Relations Onno van de Stolpe - Chief Executi
0
Pharma Stock Roundup: AZN Reports Q4 Results, NVS, PFE Drugs Get EU Approval
http://www.zacks.com/stock/news/777121/pharma-stock-roundup-azn-reports-q4-results-nvs-pfe-drugs-get-eu-approval?cid=CS-ZC-FT-analyst_blog|stock_roundup-777121
Feb 21, 2020 - AstraZeneca's (AZN) Q4 results were disappointing. European Commission approves Novartis (NVS) and Pfizer's (PFE) new drugs.
0
Page 1>